Zynerba Pharmaceuticals announces pricing of public offering of common stock
Zynerba announced pricing of an underwritten public offering of 4,062,500 shares of its common stock at a price of $8.00 per share, for gross receipt of $32.5 million. In addition, Zynerba granted underwriters a 30-day option to purchase up to 609,375 additional shares of common stock. July 20, 2018